
Peptides. Animal-derived thyroid products. The perils of not documenting enough. A new recommendation for state regulation. And more. Besides the most interesting (and important) news from the pharmacy compounding world, this episode we’ve got a deep dive into the unique tax issues compounders face — which can be pretty darned daunting. Links from the episode APC issue brief on peptide compounding (two-page PDF): https://fllw.me/47mZu7b Citizen petition to FDA on compounding ADT (83-page (!) PDF): https://fllw.me/3VeA9tw FDA’s proposed GFI 256B — info and a chance to comment: https://www.regulations.gov/search?searchTerm=FDA-2018-D-4533 APC’s exclusive processing rates: https://apcpayments.com NABP’s model pharmacy act: https://nabp.pharmacy/members/board-resources/model-pharmacy-act-rules/ Sykes & Company Pharmacy Accounting Services: https://www.sykes-cpa.com/compounding-pharmacy-services
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

PBM Impact on Independent Pharmacy Owners | PBM Reform

inSPire 2026 Rewind; The Hub of Specialty Pharmacy | Part One

Healing in Community with Sacred Plant Medicine w/ Kathy Orah Sionit | The Holistic Pharmacy Podcast

Patients Rising Rx with Terry Wilcox | PBM Reform with APCI
Free AI-powered recaps of Pharmacy Podcast Network and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.